Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis
- PMID: 30453944
- PMCID: PMC6245556
- DOI: 10.1186/s12902-018-0313-8
Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis
Abstract
Background: After hormonal replacement therapy (HRT) including androgen replacement or sequential therapy of estrogen and progesterone, The combination of human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG) and pulsatile GnRH, is not sufficient to produce sufficient gametes in some patients with Congenital hypogonadotropic hypogonadism (CHH). A Systematic review and meta-analysis was performed to determine that assisted reproductive techniques (ART) can effectively treat different causes of infertility.
Methods: To determine the effect of ART on fertility of CHH patients and investigate whether outcomes are similar to infertility due to other causes, we conducted a systematic review and meta-analysis of retrospective trials. Clinical trials were systematically searched in Medline, Embase, and the Cochrane central register of controlled trials databases. The keywords and major terms covered "hypogonadotropic hypogonadism", "kallmann syndrome", "assisted reproductive techniques", "intrauterine insemination", "intracytoplasmic sperm injection", "testicular sperm extraction", "in vitro fertilization", "embryo transplantation" and "intra-Fallopian transfer".
Results: A total of 388 pregnancies occurred among 709 CHH patients who received ART (effectiveness 46, 95% confidence interval 0.39 to 0.53) in the 20 studies we included. The I2 in trials assessing overall pregnancy rate (PR) per embryo transfer (ET) cycle was 73.06%. Similar results were observed in subgroup analysis by different gender. Regression indicates pregnancy rate decreases with increasing age. Fertilization, implantation and live birth rates (72, 36 and 40%) showed no significant differences as compared to infertility due to other causes.
Conclusions: Despite CHH patients usually being difficult to generate gametes, their actual chances of fertility are similar to subjects with other non-obstructive infertility. ART is a suitable option for CHH patients who do not conceive after long-term gonadotropin treatment.
Keywords: Assisted reproductive techniques; Congenital hypogonadotropic hypogonadism; Fertility; Hormonal replacement therapy.
Conflict of interest statement
Ethics approval and consent to participate
All analyses were based on previous published studies, thus no ethical approval and patient consent are required according to the regulation of Peking Union Medical College Hospital ethic committee. All previous published studies were approved by ethics committee respectively.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures






Similar articles
-
Current landscape of fertility induction in males with congenital hypogonadotropic hypogonadism.Ann N Y Acad Sci. 2024 Oct;1540(1):133-146. doi: 10.1111/nyas.15214. Epub 2024 Aug 27. Ann N Y Acad Sci. 2024. PMID: 39190467 Review.
-
Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.J Sex Med. 2020 Apr;17(4):645-657. doi: 10.1016/j.jsxm.2020.01.011. Epub 2020 Mar 12. J Sex Med. 2020. PMID: 32171629
-
Pulsatile gonadotropin-releasing hormone therapy: comparison of efficacy between functional hypothalamic amenorrhea and congenital hypogonadotropic hypogonadism.Fertil Steril. 2025 Feb;123(2):270-279. doi: 10.1016/j.fertnstert.2024.08.354. Epub 2024 Sep 2. Fertil Steril. 2025. PMID: 39233038
-
The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.Clin Endocrinol (Oxf). 2018 Jan;88(1):77-87. doi: 10.1111/cen.13481. Epub 2017 Oct 16. Clin Endocrinol (Oxf). 2018. PMID: 28960429
-
Hypogonadotropic hypogonadism revisited.Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):81-8. doi: 10.6061/clinics/2013(sup01)09. Clinics (Sao Paulo). 2013. PMID: 23503957 Free PMC article. Review.
Cited by
-
Management Outcomes in Males With Hypogonadotropic Hypogonadism Treated With Gonadotropins.Cureus. 2023 Feb 28;15(2):e35601. doi: 10.7759/cureus.35601. eCollection 2023 Feb. Cureus. 2023. PMID: 37007338 Free PMC article.
-
Current landscape of fertility induction in males with congenital hypogonadotropic hypogonadism.Ann N Y Acad Sci. 2024 Oct;1540(1):133-146. doi: 10.1111/nyas.15214. Epub 2024 Aug 27. Ann N Y Acad Sci. 2024. PMID: 39190467 Review.
-
Successful pregnancy and delivery after a vitrified-warmed embryo transfer in a woman with Kallmann syndrome: A case report and literature review.Fukushima J Med Sci. 2022 Apr 8;68(1):49-55. doi: 10.5387/fms.2021-09. Epub 2022 Mar 19. Fukushima J Med Sci. 2022. PMID: 35314524 Free PMC article. Review.
-
Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases.Turk J Obstet Gynecol. 2020 Dec;17(4):314-317. doi: 10.4274/tjod.galenos.2020.65031. Epub 2020 Dec 10. Turk J Obstet Gynecol. 2020. PMID: 33343979 Free PMC article.
-
Abstracts of the 3 rd REDLARA Northwest Region Meeting, Quito, Ecuador, 8-9 November 2019.JBRA Assist Reprod. 2020 Jan 30;24(1):89-94. doi: 10.5935/1518-0557.20190073. JBRA Assist Reprod. 2020. PMID: 31997632 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials